METHOD AND MOBILE TERMINAL FOR CONTROLLING DISPLAY OF WAITING INFORMATION DURING PROGRAM STARTUP
    5.
    发明申请
    METHOD AND MOBILE TERMINAL FOR CONTROLLING DISPLAY OF WAITING INFORMATION DURING PROGRAM STARTUP 有权
    用于控制程序启动期间等待信息显示的方法和移动终端

    公开(公告)号:US20120256935A1

    公开(公告)日:2012-10-11

    申请号:US13517315

    申请日:2011-01-24

    申请人: Jian Zuo

    发明人: Jian Zuo

    IPC分类号: G09G3/36 G09G5/36

    摘要: A method and a mobile terminal for controlling display of waiting information during program startup are disclosed, relating to the field of computers. In the invention, a step of initializing a liquid crystal display (LCD) by a kernel is eliminated, and an LCD controller is reinitialized after the waiting information data in a bootloader display memory is copied to the display memory of the kernel, therefore, the LCD can directly read the waiting information data in the display memory of the kernel according to a display memory first address in the LCD controller. The waiting information data in the bootloader display memory is copied to the display memory of the kernel in advance, therefore, the displayed content is not changed completely for users. In addition, the step of initializing the LCD is eliminated, so that the phenomena of distortion, flashing, blurred screen and the like of the LCD screen display are completely avoided, the display quality during program startup is improved, and better visual experience is brought for users.

    摘要翻译: 公开了一种用于在程序启动期间控制等待信息显示的方法和移动终端,涉及计算机领域。 在本发明中,消除了由内核初始化液晶显示器(LCD)的步骤,并且在引导加载器显示存储器中的等待信息数据被复制到内核的显示存储器之后,LCD控制器被重新初始化,因此, LCD可以根据LCD控制器中的显示存储器第一地址直接读取内核的显示存储器中的等待信息数据。 引导加载程序显示存储器中的等待信息数据被预先复制到内核的显示存储器,因此显示的内容不会被用户完全改变。 此外,消除了初始化LCD的步骤,从而完全避免了LCD屏幕显示的失真,闪烁,屏幕等模糊现象,提高了程序启动期间的显示质量,并提供了更好的视觉体验 为用户。

    Method and mobile terminal for controlling display of waiting information during program startup
    6.
    发明授权
    Method and mobile terminal for controlling display of waiting information during program startup 有权
    方法和移动终端,用于在程序启动期间控制等待信息的显示

    公开(公告)号:US09201660B2

    公开(公告)日:2015-12-01

    申请号:US13517315

    申请日:2011-01-24

    申请人: Jian Zuo

    发明人: Jian Zuo

    IPC分类号: G06F9/44 G09G5/395 G09G5/399

    摘要: A method and a mobile terminal for controlling display of waiting information during program startup are disclosed, relating to the field of computers. In the invention, a step of initializing a liquid crystal display (LCD) by a kernel is eliminated, and an LCD controller is reinitialized after the waiting information data in a bootloader display memory is copied to the display memory of the kernel, therefore, the LCD can directly read the waiting information data in the display memory of the kernel according to a display memory first address in the LCD controller. The waiting information data in the bootloader display memory is copied to the display memory of the kernel in advance, therefore, the displayed content is not changed completely for users. In addition, the step of initializing the LCD is eliminated, so that the phenomena of distortion, flashing, blurred screen and the like of the LCD screen display are completely avoided, the display quality during program startup is improved, and better visual experience is brought for users.

    摘要翻译: 公开了一种用于在程序启动期间控制等待信息显示的方法和移动终端,涉及计算机领域。 在本发明中,消除了由内核初始化液晶显示器(LCD)的步骤,并且在引导加载器显示存储器中的等待信息数据被复制到内核的显示存储器之后,LCD控制器被重新初始化,因此, LCD可以根据LCD控制器中的显示存储器第一地址直接读取内核的显示存储器中的等待信息数据。 引导加载程序显示存储器中的等待信息数据被预先复制到内核的显示存储器,因此显示的内容不会被用户完全改变。 此外,消除了初始化LCD的步骤,从而完全避免了LCD屏幕显示的失真,闪烁,屏幕等模糊现象,提高了程序启动期间的显示质量,并提供了更好的视觉体验 为用户。

    Anti-cancer agents
    9.
    发明申请
    Anti-cancer agents 审中-公开
    抗癌剂

    公开(公告)号:US20060160895A1

    公开(公告)日:2006-07-20

    申请号:US11292321

    申请日:2005-12-01

    IPC分类号: A61K31/22 A61K31/12

    CPC分类号: A61K31/12 A61K31/22

    摘要: This invention relates to a method of treating gastric adenocarcinoma or lung carcinoma by administering to a subject in need thereof an effective amount of an effective amount of a diterpene compound of the following formula: wherein R1, R2, R3, R4, and R5 are defined herein.

    摘要翻译: 本发明涉及通过向有需要的受试者施用有效量的有效量的下式的双萜化合物来治疗胃腺癌或肺癌的方法:其中R 1,R 2, 本文定义了R 2,R 3,R 4和R 5。